Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
Boucly A, Weatherald J, Savale L, de Groote P, Cottin V, Prévot G, Chaouat A, Picard F, Horeau-Langlard D, Bourdin A, Jutant EM, Beurnier A, Jevnikar M, Jaïs X, Simonneau G, Montani D, Sitbon O, Humbert M. Boucly A, et al. Among authors: de groote p. Eur Respir J. 2022 Jun 30;59(6):2102419. doi: 10.1183/13993003.02419-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34737227 Free PMC article.
[Pulmonary arterial hypertension in systemic sclerosis: definition of a screening algorithm for early detection (the ItinérAIR-Sclérodermie Study)].
Hachulla E, Gressin V, Guillevin L, de Groote P, Cabane J, Carpentier P, Francès C, Kahan A, Humbert M; ItinérAIR-Sclérodermie Study. Hachulla E, et al. Among authors: de groote p. Rev Med Interne. 2004 May;25(5):340-7. doi: 10.1016/j.revmed.2004.01.019. Rev Med Interne. 2004. PMID: 15110951 Review. French.
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Francès C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M. Hachulla E, et al. Among authors: de groote p. Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433. Arthritis Rheum. 2005. PMID: 16320330 Free article. Clinical Trial.
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.
Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M; ItinérAIR-Sclérodermie Study Investigators. Hachulla E, et al. Among authors: de groote p. Rheumatology (Oxford). 2009 Mar;48(3):304-8. doi: 10.1093/rheumatology/ken488. Epub 2009 Jan 27. Rheumatology (Oxford). 2009. PMID: 19174571 Free PMC article.
Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome.
Hachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, Mouthon L, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M; French PAH-SSc Network. Hachulla E, et al. Among authors: de groote p. Rheumatology (Oxford). 2010 May;49(5):940-4. doi: 10.1093/rheumatology/kep449. Epub 2010 Feb 8. Rheumatology (Oxford). 2010. PMID: 20144930
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G. Bergot E, et al. Among authors: de groote p. Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22. Int J Cardiol. 2014. PMID: 24529947
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.
Sanges S, Launay D, Rhee RL, Sitbon O, Hachulla É, Mouthon L, Guillevin L, Rottat L, Montani D, De Groote P, Cottin V, Magro P, Prévot G, Bauer F, Bergot E, Chabanne C, Reynaud-Gaubert M, Leroy S, Canuet M, Sanchez O, Gut-Gobert C, Dauphin C, Pison C, Boissin C, Habib G, Clerson P, Conesa F, Cordier JF, Kawut SM, Simonneau G, Humbert M. Sanges S, et al. Among authors: de groote p. Ann Rheum Dis. 2016 Aug;75(8):1457-65. doi: 10.1136/annrheumdis-2015-207336. Epub 2015 Aug 31. Ann Rheum Dis. 2016. PMID: 26324844 Clinical Trial.
Initial dual oral combination therapy in pulmonary arterial hypertension.
Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G. Sitbon O, et al. Among authors: de groote p. Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17. Eur Respir J. 2016. PMID: 26989105 Free article.
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. Boucly A, et al. Among authors: de groote p. Eur Respir J. 2017 Aug 3;50(2):1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775050 Free article.
267 results